Kronos Bio Inc (KRON)
0.963
-0.04
(-3.70%)
USD |
NASDAQ |
Jan 06, 16:00
0.963
0.00 (0.00%)
After-Hours: 20:00
Kronos Bio Total Liabilities (Quarterly): 38.90M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.173B |
| PTC Therapeutics Inc | 2.897B |
| Soleno Therapeutics Inc | 32.01M |
| PMV Pharmaceuticals Inc | 25.59M |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 150.02M |
| Shareholders Equity (Quarterly) | 111.13M |
| Current Ratio | 8.316 |